Using Supervised Machine Learning Algorithms to Screen Down Syndrome and Identify the Critical Protein Factors

Down syndrome (DS) is a genetic disorder caused by trisomy of all or part of the human chromosome 21. Since currently there is no cure for Down syndrome, the screening tests became the most efficient ways for DS prevention. Here, we used various supervised learning algorithms to build DS classification/screening models based on the protein/protein modification expression level of mice DS model Ts65Dn. Furthermore, we applied an adaptive boosted Decision Tree method to identify the most correlated and informative proteins factors that were associated with DS biological processes and pathways. Moreover, we improved the DS classification/screening models by using these selected DS related critical proteins. Finally, we used unsupervised learning algorithms to confirm the results we obtained above. These selected DS related proteins could be further used for protein-related and coding gene-related drugs developments.

[1]  J. D. de Winter,et al.  Clinical practice , 2010, European Journal of Pediatrics.

[2]  Stylianos E. Antonarakis,et al.  Down syndrome and the complexity of genome dosage imbalance , 2016, Nature Reviews Genetics.

[3]  Alena V. Savonenko,et al.  Increased Sparsity of Hippocampal CA1 Neuronal Ensembles in a Mouse Model of Down Syndrome Assayed by Arc Expression , 2017, Front. Neural Circuits.

[4]  C. Spong,et al.  Prevention of Developmental Delays in a Down Syndrome Mouse Model , 2008, Obstetrics and gynecology.

[5]  Jessica Yu,et al.  Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome , 2017, Neurobiology of Disease.

[6]  Stylianos E. Antonarakis,et al.  Down Syndrome: From Understanding the Neurobiology to Therapy , 2010, The Journal of Neuroscience.

[7]  K. Gardiner,et al.  Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations , 2014, Drug design, development and therapy.

[8]  Yueming Ding,et al.  Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn , 2011, Mammalian Genome.

[9]  David Patterson,et al.  Molecular genetic analysis of Down syndrome , 2009, Human Genetics.

[10]  Bridget M. Kuehn,et al.  Treating trisomies: Prenatal Down's syndrome therapies explored in mice , 2016, Nature Medicine.

[11]  Gaël Varoquaux,et al.  Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..

[12]  K. Cios,et al.  Self-Organizing Feature Maps Identify Proteins Critical to Learning in a Mouse Model of Down Syndrome , 2015, PloS one.

[13]  C. Su,et al.  Effectiveness of virtual reality using Wii gaming technology in children with Down syndrome. , 2011, Research in developmental disabilities.